Health Care: Drugs

Array BioPharma Inc (ARRY: NASDAQ)

$5.66 n/a | n/a%
09/01/15 - 03:59 PM ET
Company Income Statement
Jun 2015 Jun 2014 Jun 2013 Jun 2012
Sales 51.91M 42.08M 69.58M 85.14M
Cost of Sales 40.69M 41.46M 25.73M 19.18M
Gross Operating Profit 11.22M 619.00K 43.85M 65.95M
Selling, General, and Administrative Expenses 31.43M 21.91M 19.62M 15.20M
Research & Development 54.44M 49.82M 59.42M 56.72M
Operating Income before D & A (EBITDA) -74.66M -71.11M -35.19M -5.97M
Depreciation & Amortization 3.70M 4.51M 4.35M 5.08M
Interest Income 68.00K 77.00K 55.00K 32.00K
Other Income - Net 97.91M 0.00 -11.20M -942.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 19.62M -75.54M -50.68M -11.96M
Interest Expense 10.25M 9.72M 11.26M 11.62M
Pre-Tax Income 9.37M -85.26M -61.94M -23.58M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 9.37M -85.26M -61.94M -23.58M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 9.37M -85.26M -61.94M -23.58M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 9.37M -85.26M -61.94M -23.58M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
9.37M -85.26M -61.94M -23.58M
Preferred Dividends
Net Income Available To Common 9.37M -85.26M -61.94M -23.58M
Basic EPS from Continuing Ops. 0.07 -0.69 -0.57 -0.33
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.07 -0.69 -0.57 -0.33
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.07 -0.69 -0.57 -0.33
Basic Normalized Net Income/Share 0.07 -0.69 -0.57 -0.33
EPS fr Continuing Ops. 0.07 -0.69 -0.57 -0.33
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.07 -0.69 -0.57 -0.33
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.07 -0.69 -0.57 -0.33
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.07 -0.69 -0.57 -0.33
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ARRY

Latest ARRY Headlines from TheStreet

More Financial News for ARRY

Press Releases for ARRY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter